Target intelligence / Profile preview

Escherichia coli F41 pilus antigen (F41)

Target
F41
Molecular classification
Bacterial adhesin, Pilus protein, Fimbrial protein
01

Overview

The Escherichia coli F41 pilus antigen is a fimbrial adhesin found on the surface of specific enterotoxigenic Escherichia coli (ETEC) strains, which are major causes of neonatal diarrhea (colibacillosis) in calves and piglets. This filamentous protein structure mediates the initial attachment of the bacteria to receptors on the host's intestinal epithelial cells, such as glycophorin AM, which is a critical step for bacterial colonization and the subsequent delivery of enterotoxins. F41 is frequently co-expressed with other fimbriae, most notably K99 (also known as F5), and its presence is highly correlated with virulence in young livestock. As a key virulence factor, F41 serves as a primary target for veterinary vaccines designed to immunize pregnant dams. These vaccines induce high titers of F41-specific antibodies in the colostrum, which, when ingested by the newborn, provide passive protection by sterically hindering the bacterial pilus from binding to the gut wall, thereby preventing infection and the associated diarrheal disease.

Other names
F41 fimbriaeF41 adhesinF41 antigenF41 pilusF41 major fimbrial subunit
02

Mechanism of action

Induction of maternal antibodies (IgG and IgA) that are transferred to neonates via colostrum to provide passive immunity by blocking the adhesion of F41-expressing E. coli to the intestinal mucosa.

03

Biological functions

AdhesionColonizationHemagglutination
04

Disease associations

InfectionNeonatal diarrheaColibacillosis
05

Safety considerations

Antigenic variationCo-expression with other fimbriae (e.g., K99/F5) necessitating multivalent vaccine formulationsLimited protection if the challenge strain lacks the F41 antigen
06

Interacting drugs

Bovilis Rotavec Corona

3 more in the full profile.

07

Biomarkers

F41-specific antibody titers (ELISA)F41 antigen detection (Immunofluorescence/PCR)

Beyond the preview

Go deeper on Escherichia coli F41 pilus antigen (F41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli F41 pilus antigen (F41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call